Silo Pharma Eulerpool News

Silo Pharma Notizie Azioni

Silo Pharma è seguito da molti giornalisti e investitori in tutto il mondo. Qui raccogliamo le più recenti notizie Silo Pharma.

• 9 gennaio ·

  Yahoo
  Silo Pharma awarded U.S. patent for PTSD treatment
• 8 gennaio ·

  Yahoo
  Silo Pharma Awarded US Patent for Groundbreaking PTSD Treatment and Prepares for SPC-15 Clinical Trial
• 2 gennaio ·

  Yahoo
  Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain
• 19 dicembre ·

  Yahoo
  Silo Pharma initiates pharmacokinetic, tolerability study for SP-26
• 18 dicembre ·

  Yahoo
  Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia
• 29 novembre ·

  Yahoo
  Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management
• 18 novembre ·

  Yahoo
  Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders
• 15 novembre ·

  Yahoo
  Silo Pharma Third Quarter 2024 Earnings: US$0.22 loss per share (vs US$0.21 loss in 3Q 2023)
• 10 settembre ·

  Yahoo
  Silo Pharma Announces Completion of FDA Pre-IND Meeting to Advance Development of SPC-15 for Treatment of PTSD
• 10 settembre ·

  Thefly.com
  Silo Pharma completes pre-IND meeting with FDA regarding SPC-15